Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Rating) CFO David Afshar purchased 10,000 shares of the firm's stock in a transaction dated Wednesday, August 24th. The shares were bought at an average price of $2.01 per share, with a total value of $20,100.00. Following the purchase, the chief financial officer now owns 288,240 shares in the company, valued at $579,362.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Aveanna Healthcare Price Performance

NASDAQ:AVAH traded up $0.01 during trading hours on Wednesday, hitting $1.93. The stock had a trading volume of 171,881 shares, compared to its average volume of 447,102. The company has a 50 day simple moving average of $2.28 and a two-hundred day simple moving average of $3.31. The company has a debt-to-equity ratio of 6.19, a current ratio of 0.81 and a quick ratio of 0.81. Aveanna Healthcare Holdings Inc. has a one year low of $1.89 and a one year high of $9.91. The firm has a market capitalization of $358.82 million, a price-to-earnings ratio of -0.62 and a beta of 1.03.

Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last announced its quarterly earnings results on Wednesday, August 10th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.03). Aveanna Healthcare had a negative net margin of 33.32% and a positive return on equity of 9.57%. During the same quarter in the prior year, the company earned $0.08 earnings per share. Research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Stephens decreased their price target on shares of Aveanna Healthcare to $2.75 in a research note on Friday, July 22nd. Credit Suisse Group decreased their price target on shares of Aveanna Healthcare to $5.50 in a research note on Friday, July 22nd. Raymond James cut their price objective on shares of Aveanna Healthcare from $8.00 to $6.00 and set a "strong-buy" rating for the company in a report on Monday, August 15th. Bank of America downgraded shares of Aveanna Healthcare from a "neutral" rating to an "underperform" rating and cut their price objective for the stock from $3.00 to $2.00 in a report on Tuesday, June 21st. Finally, Jefferies Financial Group downgraded shares of Aveanna Healthcare from a "buy" rating to a "hold" rating and set a $2.50 price objective for the company. in a report on Friday, July 22nd. One analyst has rated the stock with a sell rating, three have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $5.33.

About Aveanna Healthcare

(Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.

Read More

• Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
• NYSE Stocks Give Investors a Variety of Quality Options
• Zoom Video Communications Valuation Is Realigned With Reality
• The J.M. Smucker Company Proves Why Staples Are Outperforming
• Will the Real Palantir Please Stand Up?
• Foot Locker Just Because A Very Tempting Buy

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.